STIPE Therapeutics ApS is a Danish APS based in København V, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company has 1 employee and reported a gross profit of -DKK 842.3k in its latest annual filing.
EBITDA margin (of gross profit) 178.1 %
+70% vs 2023
Solidity ratio Equity ÷ Total assets × 100 Among the 20% highest rated companies in the industry
2020 2024
Liquidity ratio Current assets ÷ Short-term debt Among the 10% highest rated companies in the industry
2020 2024
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 10% highest rated companies in the industry
2020 2024
EBITDA — year on year DKK thousands 0 -2742 -5485 -8227 -10970 2020: -4557 -4557 2020 2021: -6077 (-33% vs 2020) -6077 -33% 2021 2022: -8809 (-45% vs 2021) -8809 -45% 2022 2023: -4958 (+44% vs 2022) -4958 +44% 2023 2024: -1500 (+70% vs 2023) -1500 +70% 2024
Key figures Annual report 2024 Gross profit -0.8M DKK -76% EBITDA -1.5M DKK +70% Net profit 1.4M DKK +133% Total assets 1.1M DKK -65% Equity 1.1M DKK +144% Employees 1 —
Legal name
STIPE Therapeutics ApS
Founded
2 July 2018 · 8 years
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
(no translation available)
Email
prj@gorrissenfederspiel.com
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.comExplore Companies in Research and experimental development on natural sciences and engineering Companies in København All Denmark companiesFinancial development In its most recent annual report (2024), STIPE Therapeutics ApS reported a gross profit of -DKK 842.3k. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net profit of DKK 1.4m.
At the end of 2024, equity financed 96.8% of the balance sheet, and current assets covered short-term debt 31.1 times. STIPE Therapeutics ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of STIPE Therapeutics ApS? STIPE Therapeutics ApS is registered with CVR / Virk under CVR 39691175.
What is the gross profit of STIPE Therapeutics ApS? STIPE Therapeutics ApS reported a gross profit of -DKK 842.3k in 2024.
How many employees does STIPE Therapeutics ApS have? STIPE Therapeutics ApS employs 1 people as of the latest annual report.
Where is STIPE Therapeutics ApS headquartered? STIPE Therapeutics ApS's registered address is Axeltorv 2.
More on STIPE Therapeutics ApS